📚 Lecture Overview
This lecture covers the etiology, pathogenesis, clinical features, laboratory diagnosis, and prevention of bacterial meningitis, with a dedicated focus on Neisseria meningitidis. It highlights the critical clinical and laboratory distinctions between purulent (septic) bacterial meningitis and aseptic (viral/tubercular) meningitis. Understanding these distinctions is vital for rapid diagnosis and emergency antimicrobial intervention.
🎯 Key Concepts & Definitions
- Septic (Purulent) Meningitis: Acute bacterial inflammation of the meninges characterized by cloudy/turbid CSF, elevated polymorphonuclear neutrophils (PMNs), low CSF glucose, and high CSF protein.
- Aseptic Meningitis: Non-purulent meningeal inflammation (most commonly viral) presenting with clear CSF, lymphocytic predominance, normal glucose levels, and mildly elevated protein.
- Waterhouse-Friderichsen Syndrome: A severe, fulminant form of meningococcemia driven by endotoxins, leading to massive bilateral adrenal hemorrhage, DIC, circulatory collapse, and rapid death within 10–12 hours.
- IgA Protease: Pathogenic enzyme produced by bacteria like N. meningitidis and H. influenzae that cleaves host secretory IgA, facilitating mucosal colonization and invasion.
- Conjugate Vaccine: A vaccine coupling a bacterial polysaccharide antigen with a protein carrier, inducing a T-cell-dependent immune response effective in infants under 2 years of age and reducing asymptomatic nasopharyngeal carriage.
📖 Main Content
1. Etiology of Meningitis by Age Group & Clinical Setting
Meningitis causes vary according to host age, immune status, and clinical interventions:
| Host Group / Setting | Major Causative Organisms | Key Microbiological Traits & Transmission |
|---|---|---|
| Neonates (<3 months) | Streptococcus agalactiae (Group B) | Gram-positive cocci in chains, $\beta$-hemolytic, Catalase negative. Genital tract flora. |
| Escherichia coli | Gram-negative bacilli, lactose fermenter. Virulence factors present. | |
| Listeria monocytogenes | Gram-positive bacilli. Transplacental (<2 days) or intrapartum exposure (2–3 weeks). | |
| Children (6 months – 5 years) | Haemophilus influenzae (Type b) | Gram-negative bacilli. Droplet contact. Enhanced by prior viral infection. |
| Infants to Young Adults | Neisseria meningitidis | Gram-negative diplococci. Droplet transmission via respiratory secretions. |
| All Ages / Elderly | Streptococcus pneumoniae | Gram-positive lancet-shaped diplococci. Endogenous or droplet transmission. |
| Special Conditions | Staphylococcus epidermidis | Associated with CNS shunts. |
| Pseudomonas aeruginosa | Postoperative surgical complications. |
2. Pathogenesis of Bacterial Meningitis
Bacterial invasion of the Central Nervous System follows a predictable step-by-step sequence:
- Nasopharyngeal Colonization: Pathogens attach to the nasopharyngeal mucosa using structures like pili and evade local IgA antibodies via IgA protease.
- Local Mucosal Invasion: Pathogens cross the epithelial mucosal barrier to gain access to the bloodstream.
- Bacteremia: Survival and multiplication within the circulation, evading host phagocytosis.
- CNS Entry: Pathogens cross the blood-brain barrier to enter the subarachnoid space.
- Meningeal Inflammation: Unchecked bacterial replication in the CSF triggers a severe inflammatory cytokine cascade.
3. Laboratory Diagnosis & CSF Differentiation
Laboratory diagnosis relies on comparing CSF parameters between health, purulent meningitis, and aseptic meningitis.
| Laboratory Parameter | Normal Range | Purulent (Bacterial) Meningitis | Aseptic (Viral/TB) Meningitis |
|---|---|---|---|
| Macroscopic Appearance | Clear | Turbid / Purulent | Clear / Slightly cloudy |
| Cell Count & Type | 0–5 cells/mm³ (Lymphocytes) | 5 – 20,000 cells/mm³ (Polymorphs/PMNs) | 5 – 2,000 cells/mm³ (Lymphocytes) |
| CSF Glucose | 50–100 mg/dL | Markedly Reduced | Normal (Viral) / Reduced (TB) |
| CSF Protein | 15–50 mg/dL | Markedly Elevated | Mildly Raised |
Empirical Antibiotic Treatment
- Administer Ceftriaxone or Cefotaxime PLUS Vancomycin immediately to cover common gram-positive and gram-negative bacterial etiologies.
4. Special Focus: Neisseria meningitidis (Meningococcus)
General Features
- Microbiology: Gram-negative diplococci with a polysaccharide capsule. Highly sensitive to cold, drying, and desiccation.
- Serogroups: Classified into 13 serogroups based on capsular polysaccharide.
- A, B, C, Y, W-135 are clinical drivers.
- Serogroups A and C are predominantly responsible for epidemics.
Determinants of Pathogenicity
- Polysaccharide Capsule: Protects against phagocytosis.
- Pili: Mediates attachment to nasopharyngeal epithelial cells.
- Outer Membrane Protein (OMP): Facilitates cell adhesion.
- Lipopolysaccharide (LPS): Endotoxin responsible for fever, purpura, petechial rash, and septic shock.
- IgA Protease: Cleaves mucosal IgA to allow mucosal penetration.
Clinical Presentations
- Bacteremia: Mild flu-like upper respiratory symptoms.
- Meningococcal Meningitis: Fever, headache, stiff neck, joint symptoms, and a pathognomonic petechial rash.
- Fulminant Meningococcemia: Rapidly progressive septic shock leading to Waterhouse-Friderichsen syndrome.
Carrier Detection vs. Diagnostic Culture
- Diagnostic CSF/Blood Samples: Inoculate directly onto enriched media; perform Gram stain (gram-negative intracellular diplococci).
- Carrier Detection: Nasopharyngeal sampling using a bent West swab passed behind the soft palate. Inoculate onto selective Thayer-Martin agar at 37°C in 5–10% $CO_2$.
Prevention Strategy
- Polysaccharide Vaccines: Available in tetravalent forms; ineffective in children <2 years; produces short-term immunity without reducing nasopharyngeal carriage.
- Conjugate Vaccines: Protein-coupled capsular antigen; induces T-cell-dependent memory, effective in infants under 2 years, and reduces carriage.
- Chemoprophylaxis: Administered to close/household contacts to eradicate carriage:
* First-line: Rifampin
* Adults: Ciprofloxacin
* Children: Ceftriaxone
📊 Visual Learning
💡 Important Points to Remember
- Neonate Pathogens: S. agalactiae, E. coli, and Listeria monocytogenes cause the vast majority of neonatal meningitis cases.
- Pediatric Shift: H. influenzae type b incidence has dropped drastically since the introduction of routine pediatric conjugate vaccination.
- CSF PMNs vs. Lymphocytes: Bacterial meningitis yields PMNs/polymorphs; viral meningitis yields lymphocytes.
- CSF Glucose Key Rule: Low CSF glucose strongly points to bacterial meningitis; viral meningitis leaves CSF glucose normal.
- Cold Sensitivity: N. meningitidis is delicate and sensitive to temperature drop or desiccation; CSF specimens must not be refrigerated before processing.
- Pathognomonic Sign: A petechial rash in a feverish patient with meningeal signs strongly indicates Neisseria meningitidis.
- Carrier Swabbing: Nasopharyngeal carrier state is detected specifically using a West swab cultured on Thayer-Martin agar.
- Age Threshold for Vaccines: Pure polysaccharide capsular vaccines fail to stimulate adequate immunity in infants under 2 years old. Conjugate vaccines solve this via T-cell engagement.
- Carrier Prophylaxis: Close contacts receive Rifampin, Ciprofloxacin (adults), or Ceftriaxone (children).
- Waterhouse-Friderichsen Shock: Caused primarily by circulating LPS endotoxin resulting in fatal adrenal hemorrhage.
⚠️ Common Exam Questions & Traps
Common Exam Traps & Tricks
-
The Nasopharyngeal Swab Trap:
* Exam Trick: A question asks for the diagnostic specimen to confirm active meningococcal meningitis in a patient presenting with high fever and neck stiffness. Option A is a Nasopharyngeal swab.
* Trap: Students pick the swab.
* Fact: Nasopharyngeal swabs are ONLY used for carrier detection surveys. Diagnostic confirmation requires CSF or blood culture. -
CSF Differentiation Trick:
* Exam Trick: Presenting CSF values showing elevated protein, elevated cell count with 85% lymphocytes, and normal glucose.
* Trap: Diagnostic choice lists S. pneumoniae or N. meningitidis.
* Fact: Normal glucose with lymphocytic predominance means it is aseptic/viral meningitis, NOT bacterial. -
Vaccine Selection in Infants:
* Exam Trick: Asking which vaccine type to administer to a 14-month-old infant for long-term protection against serogroups A, C, Y, W-135.
* Trap: Choosing the standard polysaccharide vaccine.
* Fact: Pure polysaccharide vaccines are non-immunogenic in children <2 years. You MUST select the Polysaccharide-Protein Conjugate Vaccine. -
Listeria Onset Timing:
* Exam Trick: Differentiating early-onset vs. late-onset neonatal Listeria infections.
* Fact: Early onset (<2 days of life) occurs via transplacental transmission. Late onset (2–3 weeks) occurs via contact during/after delivery.
📝 Quick Review Checklist
I can differentiate bacterial and viral meningitis based on CSF glucose, protein, and cell counts.
I know the top 3 causes of neonatal bacterial meningitis.
I can list all 5 major virulence factors of Neisseria meningitidis and their functions.
I understand why conjugate vaccines are required for children under 2 years of age.
I know which culture media (Thayer-Martin) and swab type (West swab) are used to detect meningococcal carriers.
I can name the antimicrobial agents used for empiric meningitis treatment and close-contact chemoprophylaxis.
I can identify the features of Waterhouse-Friderichsen syndrome.